Black Rock Inc. Pro Phase Labs, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 64,299 shares of PRPH stock, worth $48,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,299

Previous 57,361 12.1%

Holding current value

$48,224

Previous $371,000 27.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.18 - $7.35 $29,000 - $50,994	6,938 Added 12.1%	64,299 $268,000
Q1 2024 May 10, 2024	SELL	$4.47 - $6.47 $15,166 - $21,952	-3,393 Reduced 5.58%	57,361 $371,000
Q4 2023 Feb 13, 2024	BUY	$4.35 - $5.1 $6,785 - $7,955	1,560 Added 2.64%	60,754 $274,000
Q3 2023 Nov 13, 2023	SELL	$4.23 - $7.53 $111,574 - $198,618	-26,377 Reduced 30.82%	59,194 $258,000
Q2 2023 Aug 11, 2023	SELL	$7.15 - $9.78 $155,305 - $212,431	-21,721 Reduced 20.24%	85,571 $621,000
Q1 2023 May 12, 2023	SELL	$6.62 - $9.57 $167,035 - $241,470	-25,232 Reduced 19.04%	107,292 $817,000
Q4 2022 Feb 13, 2023	BUY	$8.78 - $12.47 $3,371 - $4,788	384 Added 0.29%	132,524 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $883,294 - $1.45 Million	98,582 Added 293.77%	132,140 $1.49 Million
Q2 2022 Aug 12, 2022	BUY	$6.52 - $13.24 $50,451 - $102,451	7,738 Added 29.97%	33,558 $425,000
Q1 2022 May 12, 2022	SELL	$6.2 - $7.87 $5,511 - $6,996	-889 Reduced 3.33%	25,820 $180,000
Q4 2021 Feb 10, 2022	SELL	$5.13 - $7.89 $10,613 - $16,324	-2,069 Reduced 7.19%	26,709 $191,000
Q3 2021 Nov 09, 2021	BUY	$4.89 - $7.82 $17,833 - $28,519	3,647 Added 14.51%	28,778 $150,000
Q2 2021 Aug 11, 2021	BUY	$4.61 - $6.83 $115,853 - $171,644	25,131 New	25,131 $156,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.71M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $12M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account